Fresenius Medical Care AG
NYSE:FMS 주식 보고서
Fresenius Medical Care 과거 수익 실적 Fresenius Medical Care의 수입은 연평균 -20.9%의 비율로 감소해 온 반면, Healthcare 산업은 수입이 연평균 5.4%의 비율로 증가했습니다. 매출은 연평균 2.7%의 비율로 증가해 왔습니다. Fresenius Medical Care의 자기자본이익률은 5.9%이고 순이익률은 3.4%입니다.
주요 정보 Healthcare 산업 성장 8.5% 매출 성장률 2.7% 자기자본 수익률 5.9% 순이익 3.4% 다음 실적 업데이트 25 Feb 2025
최근 과거 실적 업데이트
Fresenius Medical Care AG to Report Q2, 2025 Results on Aug 05, 2025 Nov 05 Fresenius Medical Care AG to Report Q1, 2025 Results on May 06, 2025 Nov 01
Fresenius Medical Care AG to Report Q4, 2024 Results on Feb 25, 2025 Aug 08
Fresenius Medical Care AG & Co. KGaA to Report Fiscal Year 2023 Final Results on Mar 22, 2024 Nov 07
Fresenius Medical Care AG & Co. KGaA to Report Q1, 2024 Results on May 07, 2024 Fresenius Medical Care AG & Co. KGaA to Report Q2, 2023 Results on Aug 02, 2023
모든 업데이트 표시
Fresenius Medical Care AG to Report Q2, 2025 Results on Aug 05, 2025 Nov 05 Fresenius Medical Care AG to Report Q1, 2025 Results on May 06, 2025 Nov 01
Fresenius Medical Care: Let's Look At The Upside Oct 04 Fresenius Medical Care AG to Report Q4, 2024 Results on Feb 25, 2025 Aug 08
Fresenius Medical Care AG Confirms Earnings Guidance for the Fiscal Year 2024 Aug 01
Fresenius Medical Care: Significant Upside Remains Jun 25
Fresenius Medical Care Ag Confirms Earnings Guidance for the Fiscal Year 2024 May 08
Fresenius Medical Care Launches Augmented Reality for Training on Kidney Replacement Therapy Device Mar 19 Fresenius Medical Care AG Appoints Jörg Häring as New Global Head of Legal, Compliance and Human Resources and Also Assume the Role of Labor Director, Effective from June 1, 2024 Mar 13
Broyhill - Fresenius Medical Care: Correctly Focused On Increasing Margins And Returns Feb 23
Fresenius Medical Care AG Proposes Dividend for the Fiscal Year 2023 Feb 21 Fresenius Medical Care AG Provides Earnings Guidance for Fiscal Year 2024 Feb 20
Fresenius Medical Care Brings Dialysis Therapy to Kidney Disease Patients in the U.S Feb 09
Fresenius Medical Care Enters into Favorable Settlement Agreement with U. S. Government Nov 23 Fresenius Medical Care AG & Co. Revises Earnings Guidance for the Year 2023 Fresenius Medical Care AG & Co. KGaA to Report Fiscal Year 2023 Final Results on Mar 22, 2024 Nov 07
An Unknown buyer entered into an agreement to acquire National Cardiovascular Partners, LP from Fresenius Medical Care AG & Co. KGaA (XTRA:FME) Nov 03 Fresenius Medical Care AG & Co. KGaA to Report Q1, 2024 Results on May 07, 2024 Fresenius Medical Care Appoints Craig Cordola as New Management Board Member for Care Delivery Nov 01
Fresenius Medical Care Achieves Key Ai Milestone with First-Phase Completion of Largest Global Dialysis Clinical Dataset Oct 27
Fresenius Medical Care: Don't Let The Ozempic Kidney Failure Scare You Off Oct 12
Fresenius Medical Care Announces Fda Clearance of Versi(R)Hd with Guideme Software Aug 24 An unknown buyer acquired Local dialysis service provider business from Fresenius Medical Care AG & Co. KGaA (XTRA:FME).
Fresenius Medical Care Announces Executive Changes Jul 11
Fresenius Medical Care participated Announces Breakthrough Study Demonstrates That High-Dose Hemodiafiltration Treatment for Kidney Failure Patients Significantly Reduces Mortality Rates Jun 21
Fresenius Medical Care: Other Stocks Still Better, But Upside Exists Jun 01
Fresenius Medical Care Q4 2022 Earnings Preview Feb 21
Fresenius: The Company Is Climbing, And I'm At 'Buy' Jan 06 Fresenius Medical Care AG & Co. KGaA Announces CEO Changes Dec 06
Fresenius Medical Care AG & Co. KGaA, Annual General Meeting, May 16, 2023 Nov 16 Fresenius Medical Care AG & Co. KGaA to Report Q2, 2023 Results on Aug 02, 2023
Fresenius: A Contrarian Opportunity Not Seen For 20 Years (Technical Analysis) Oct 27
Fresenius Medical gains after report of activist Elliott stake in Fresenius SE Oct 19
Fresenius cut to Hold at Jefferies citing staffing issues and inflation Oct 10
Fresenius gets award to provide dialysis services to U.S. military veterans Aug 30
Fresenius appoints head of pharma unit as new CEO Aug 19
Fresenius Medical Care AG & Co. KGaA Revises Earnings Guidance for the Full Year 2022 Aug 03
Fresenius Medical Care: Best Time In 21 Years To Buy This High-Yield Dividend Aristocrat Jul 30
Fresenius Medical Care AG & Co. KGaA Provides Earnings Guidance for the Second Half of 2022 Jul 28
Fresenius Medical Care accused of Medicare fraud in dialysis Jul 13
Fresenius Medical Care AG & Co. KGaA to Report Q3, 2022 Final Results on Nov 09, 2022 May 15
Fresenius: The Upside Is Getting Bigger May 02
Fresenius Medical Care Appoints Nwamaka (Amaka) Eneanya as Head of Strategy and Operations for the Company's Global Medical Office Apr 06
Fresenius Medical Care AG & Co. KGaA Proposes Dividend, Due on 17 May 2022 Apr 01 Fresenius Medical Care Ag & Co. Kgaa Provides Earnings Forecast for the Year 2022
Fresenius Medical Care Reportedly in Talks to Buy Dmed Diyaliz Jan 27
Fresenius Medical Care AG & Co. KGaA Launches New Mobile App to Empower and Engage Nurses Dec 21
You Really Want To Know About Fresenius Medical Care Aug 28
Fresenius Medical Care Approves Dividend for the Fiscal Year 2020 May 21
Fresenius Medical Care Confirms Earnings Guidance for the Fiscal Year 2021 May 07
Fresenius Medical Care AG & Co. KGaA to Report Fiscal Year 2020 Final Results on Mar 23, 2021 Mar 17
Fresenius Medical Care AG & Co. KGaA to Report Q3, 2021 Results on Nov 02, 2021 Feb 24
Fresenius Medical drops 12% on disappointing 2021 outlook Feb 02
Fresenius Medical Care's Frenova Enrolls Patients in Initiative to Build Large Genomic Registry Targeting Kidney Disease Jan 12 Fresenius Medical Care AG & Co. KGaA, Annual General Meeting, May 20, 2021
Fresenius Medical Care EPS beats by €0.06, misses on revenue Oct 29
Fresenius Medical Care AG & Co. KGaA to Report Q1, 2020 Results on May 06, 2020 Sep 30
Fresenius Medical Care AG & Co. KGaA to Report Q2, 2020 Results on Jul 30, 2020 Sep 22
Fresenius Medical Care 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역 NYSE:FMS 수익, 비용 및 수입 (EUR Millions ) 날짜 수익 수익 G+A 비용 R&D 비용 30 Sep 24 19,239 659 3,148 199 30 Jun 24 19,415 530 3,186 212 31 Mar 24 19,474 484 3,190 224 31 Dec 23 19,454 499 3,196 232 30 Sep 23 19,463 450 3,156 228 30 Jun 23 19,622 596 3,180 236 31 Mar 23 19,554 602 3,163 235 31 Dec 22 19,398 673 3,170 229 30 Sep 22 19,048 763 3,104 234 30 Jun 22 18,393 806 3,018 225 31 Mar 22 17,957 878 3,091 222 31 Dec 21 17,619 969 2,773 221 30 Sep 21 17,372 918 3,011 205 30 Jun 21 17,344 998 2,986 198 31 Mar 21 17,581 1,131 2,868 197 31 Dec 20 17,859 1,164 2,966 194 30 Sep 20 18,039 1,330 2,991 190 30 Jun 20 18,044 1,309 3,016 187 31 Mar 20 17,832 1,212 3,099 185 31 Dec 19 17,477 1,200 2,944 168 30 Sep 19 17,196 1,282 2,967 138 30 Jun 19 16,835 1,234 2,978 122 31 Mar 19 16,704 1,974 2,898 111 31 Dec 18 16,547 1,982 2,857 114 30 Sep 18 16,676 1,951 3,126 131 30 Jun 18 16,954 1,975 3,185 133 31 Mar 18 17,211 1,250 3,374 130 31 Dec 17 17,784 1,280 3,640 111 30 Sep 17 17,771 1,249 3,417 134 30 Jun 17 17,647 1,244 3,407 145 31 Mar 17 17,201 1,239 3,262 144 31 Dec 16 16,570 1,144 3,133 147 30 Sep 16 16,101 1,063 3,047 143 30 Jun 16 15,841 998 3,027 136 31 Mar 16 15,402 933 2,961 130 31 Dec 15 15,455 955 2,895 128 30 Sep 15 15,345 939 2,919 118 30 Jun 15 15,246 948 2,839 114 31 Mar 15 15,428 977 2,816 115 31 Dec 14 13,329 864 2,434 101 30 Sep 14 12,413 839 2,242 97 30 Jun 14 11,112 775 1,999 91 31 Mar 14 10,882 791 1,962 91 31 Dec 13 10,816 806 1,937 91
양질의 수익: FMS 은 높은 수익 을 보유하고 있습니다.
이익 마진 증가: FMS 의 현재 순이익 이익률 (3.4%) 작년보다 높습니다 (2.3%).
과거 수익 성장 분석
수익추이: FMS 의 수입은 지난 5년 동안 매년 20.9% 씩 감소했습니다.
성장 가속화: 지난 1년간 FMS 의 수익 증가율( 46.5% )은 연간 평균( -20.9% 초과합니다. ).
수익 대 산업: 지난 1년간 FMS 수익 증가율( 46.5% )은 Healthcare 업계 10.4% 초과했습니다.
자기자본 수익률
높은 ROE: FMS 의 자본 수익률 ( 5.9% )은 낮음 으로 간주됩니다.
Simply Wall St™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}